PeckwaterPR is a full service Financial Public Relations and Investor Relations consultancy to smaller capitalised 'AIM' companies and private businesses. The agency's offering also includes a specialist competency in the delivery of strategic healthcare communications and investor relations to emerging biotech/biopharma companies. Founded in 2009, the agency has extensive experience of the healthcare sector, an exceptional contact base going back over many years and a personal, bespoke approach to delivering value for private and listed early stage, pre-clinical and clinical-stage life science clients. Communication about pioneering science, in all its guises across medicine, is a complex task and one that presents unique communications challenges. PeckwaterPR's familiarity with the sector enables it to rapidly grasp the opportunities and challenges that companies experience on their respective drug development pathways and to differentiate those clients and their technologies from their peers.